|
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study |
|
|
|
Titel: |
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study |
Auteur: |
Jackisch, C. Kim, S.-B. Semiglazov, V. Melichar, B. Pivot, X. Hillenbach, C. Stroyakovskiy, D. Lum, B.L. Elliott, R. Weber, H.A. Ismael, G. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 26 () nr. 2 pagina's 320-325 |
Jaar: |
2015 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|